Coburn JW - Search Results

1

Oral and parenteral calcitriol for the management of end-stage renal disease.

Coburn JW, Salusky IB, Norris KC, Goodman WG. Coburn JW, et al. Contrib Nephrol. 1991;90:166-82. doi: 10.1159/000420140. Contrib Nephrol. 1991. PMID: 1959343 Review. No abstract available.

2

The use of 1,25-dihydroxyvitamin D3 in early renal failure.

Goodman WG, Coburn JW. Goodman WG, et al. Among authors: coburn jw. Annu Rev Med. 1992;43:227-37. doi: 10.1146/annurev.me.43.020192.001303. Annu Rev Med. 1992. PMID: 1580587 Review.

3

Toxic effects of aluminum in end-stage renal disease: discussion of a case.

Coburn JW, Norris KC, Sherrard DJ, Bia M, Llach F, Alfrey AC, Slatopolsky E. Coburn JW, et al. Am J Kidney Dis. 1988 Sep;12(3):171-84. doi: 10.1016/s0272-6386(88)80119-7. Am J Kidney Dis. 1988. PMID: 3414675 Free article. No abstract available.

4

Calcium-sensing receptor and calcimimetic agents.

Coburn JW, Elangovan L, Goodman WG, Frazaõ JM. Coburn JW, et al. Kidney Int Suppl. 1999 Dec;73:S52-8. doi: 10.1046/j.1523-1755.1999.07303.x. Kidney Int Suppl. 1999. PMID: 10633465 Free article. Review.

5

Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism.

Frazão JM, Elangovan L, Maung HM, Chesney RW, Acchiardo SR, Bower JD, Kelley BJ, Rodriguez HJ, Norris KC, Robertson JA, Levine BS, Goodman WG, Gentile D, Mazess RB, Kyllo DM, Douglass LL, Bishop CW, Coburn JW. Frazão JM, et al. Among authors: coburn jw. Am J Kidney Dis. 2000 Sep;36(3):550-61. doi: 10.1053/ajkd.2000.16193. Am J Kidney Dis. 2000. PMID: 10977787 Clinical Trial.

6

Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison.

Maung HM, Elangovan L, Frazão JM, Bower JD, Kelley BJ, Acchiardo SR, Rodriguez HJ, Norris KC, Sigala JF, Rutkowski M, Robertson JA, Goodman WG, Levine BS, Chesney RW, Mazess RB, Kyllo DM, Douglass LL, Bishop CW, Coburn JW. Maung HM, et al. Among authors: coburn jw. Am J Kidney Dis. 2001 Mar;37(3):532-43. Am J Kidney Dis. 2001. PMID: 11228177 Clinical Trial.

7

Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.

Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard DJ. Andress DL, et al. Among authors: coburn jw. N Engl J Med. 1989 Aug 3;321(5):274-9. doi: 10.1056/NEJM198908033210502. N Engl J Med. 1989. PMID: 2631697

8

Sucralfate, intestinal aluminum absorption, and aluminum toxicity in a patient on dialysis.

Robertson JA, Salusky IB, Goodman WG, Norris KC, Coburn JW. Robertson JA, et al. Among authors: coburn jw. Ann Intern Med. 1989 Jul 15;111(2):179-81. doi: 10.7326/0003-4819-111-2-179. Ann Intern Med. 1989. PMID: 2742249 No abstract available.

9

Is the clinical expression of primary hyperparathyroidism a function of the long-term vitamin D status of the patient?

Kleeman CR, Norris K, Coburn JW. Kleeman CR, et al. Among authors: coburn jw. Miner Electrolyte Metab. 1987;13(5):305-10. Miner Electrolyte Metab. 1987. PMID: 3312988 Review. No abstract available.

10

Calcium citrate markedly enhances aluminum absorption from aluminum hydroxide.

Coburn JW, Mischel MG, Goodman WG, Salusky IB. Coburn JW, et al. Am J Kidney Dis. 1991 Jun;17(6):708-11. doi: 10.1016/s0272-6386(12)80356-8. Am J Kidney Dis. 1991. PMID: 2042654 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

398 results

Search Page

Filters